Rusya'da dördüncü korona aşısı tescillendi
Rusya'da koronavirüse karşı geliştirilen 'EpiVakKorona-N' isimli dördüncü aşının tescillendiği bildirildi.
Stay updated with breaking news from Vector Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rusya'da koronavirüse karşı geliştirilen 'EpiVakKorona-N' isimli dördüncü aşının tescillendiği bildirildi.
Rusya'da yeni tip koronavirüse karşı geliştirilen dördüncü aşının tescillendiği bildirildi.
Rusya'da yeni tip koronavirüse karşı geliştirilen dördüncü aşının tescillendiği bildirildi.
During infection, SARS-CoV-2 binds to a cellular receptor known as angiotensin converting enzyme 2 (ACE2) before entering a cell and replicating. Because it is not well established whether common blood pressure medications can increase the levels of ACE2, there has been some concern that patients taking these medications might be more susceptible to COVID-19.
The watchdog is keeping a close eye on relevant research in other countries © Anton Novoderezhkin/TASS MOSCOW, January 26. /TASS/. Immunity to the novel coronavirus infection after recovery will laso protect against the British strain, Anna Popova, chief of Russia’s sanitary watchdog, said on Tuesday. "We continue to study the virus we isolated at our Vector Research Center. I can say that the program is being implemented as scheduled but it is obvious already now that the immunity developed after the disease caused by the primary coronavirus strain is highly effective against the Britis...